Alpha-synuclein Linked To The Treatment Of Parkinson’s Disease ADC评论 July 13, 2022 There are currently no new disease-modifying therapies that can change the progression of Parkinson’s disease, but scientists from the University of Colorado and other institutions Read More »
Leveraging Azide PEG in Biopharmaceuticals: Uniting Azide Linkers and Click Chemistry October 20, 2023
Tetrazine and Methyltetrazine: Structural Distinctions and Their Roles in Pharmaceutical Research October 8, 2023
An Overview of Cyanine Dyes: Types, Wavelengths, and Applications Across Industries September 19, 2023